Back to Search Start Over

P52 - Topic: AS08-Treatment/AS08g-Clinical trials - Phase II-III: EFFICACY OF CPX-351 AS FIRST LINE TREATMENT FOR HIGHER RISK (HR) MDS/CMML. A STUDY BY THE GFM.

Authors :
Peterlin, P.
Turlure, P.
Chevallier, P.
Gourin, M.-P.
Dumas, P.-Y.
Thepot, S.
Berceanu, A.
Park, S.
Hospital, M.-A.
Cluzeau, T.
Torregrossa-Diaz, J.-M.
Devron, L.
Sapena, R.
Chermat, F.
Dimicoli-Salazar, S.
Fenaux, P.
Source :
Leukemia Research. 2021 Supplement, Vol. 108, pN.PAG-N.PAG. 1p.
Publication Year :
2021

Subjects

Subjects :
*THERAPEUTICS

Details

Language :
English
ISSN :
01452126
Volume :
108
Database :
Academic Search Index
Journal :
Leukemia Research
Publication Type :
Academic Journal
Accession number :
152556345
Full Text :
https://doi.org/10.1016/j.leukres.2021.106681.51
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details